Alector Inc

General ticker "ALEC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $227.8M

Alector Inc does not follow the US Stock Market performance with the rate: -21.2%.

Estimated limits based on current volatility of 2.5%: low 1.75$, high 1.91$

Factors to consider:

  • Current price 60.6% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [4.87$, 11.18$]
  • 2024-12-30 to 2025-12-30 estimated range: [5.68$, 12.49$]

Financial Metrics affecting the ALEC estimates:

  • Negative: Non-GAAP EPS, $ of -1.55 <= 0.10
  • Negative: Operating profit margin, % of -60.99 <= 1.03
  • Negative: Operating cash flow per share per price, % of -24.85 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term ALEC quotes

Long-term ALEC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $207.09MM $133.62MM $97.06MM
Operating Expenses $244.44MM $271.45MM $248.80MM
Operating Income $-37.36MM $-137.83MM $-151.74MM
Non-Operating Income $1.03MM $7.78MM $26.56MM
R&D Expense $189.41MM $210.42MM $192.12MM
Income(Loss) $-36.33MM $-130.06MM $-125.18MM
Taxes $0.00MM $3.25MM $5.21MM
Profit(Loss) $-36.33MM $-133.31MM $-130.39MM
Stockholders Equity $300.72MM $214.44MM $134.16MM
Assets $814.66MM $787.65MM $621.83MM
Operating Cash Flow $298.55MM $-20.33MM $-184.16MM
Capital expenditure $3.25MM $4.12MM $2.38MM
Investing Cash Flow $-49.66MM $-159.01MM $101.92MM
Financing Cash Flow $30.30MM $4.51MM $2.55MM
Earnings Per Share* $-0.35 $-1.62 $-1.56

* EPS are Split Adjusted, recent splits may be reflected with a delay.